UCB Attempts To Protect Keppra Franchise
Company asks FDA to strengthen guidelines associated with generic versions of antiepileptic drugs, as Keppra patent expiration approaches.
Company asks FDA to strengthen guidelines associated with generic versions of antiepileptic drugs, as Keppra patent expiration approaches.